59 related articles for article (PubMed ID: 22010100)
1. Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia.
Kühnl A; Gökbuget N; Kaiser M; Schlee C; Stroux A; Burmeister T; Mochmann LH; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Blood; 2011 Dec; 118(24):6362-7. PubMed ID: 22010100
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children's Oncology Group Report.
DelRocco NJ; Loh ML; Borowitz MJ; Gupta S; Rabin KR; Zweidler-McKay P; Maloney KW; Mattano LA; Larsen E; Angiolillo A; Schore RJ; Burke MJ; Salzer WL; Wood BL; Carroll AJ; Heerema NA; Reshmi SC; Gastier-Foster JM; Harvey R; Chen IM; Roberts KG; Mullighan CG; Willman C; Winick N; Carroll WL; Rau RE; Teachey DT; Hunger SP; Raetz EA; Devidas M; Kairalla JA
Leukemia; 2024 Apr; 38(4):720-728. PubMed ID: 38360863
[TBL] [Abstract][Full Text] [Related]
3. LEF1 isoforms regulate cellular senescence and aging.
Jia M; Sayed K; Kapetanaki MG; Dion W; Rosas L; Irfan S; Valenzi E; Mora AL; Lafyatis RA; Rojas M; Zhu B; Benos PV
Aging Cell; 2023 Dec; 22(12):e14024. PubMed ID: 37961030
[TBL] [Abstract][Full Text] [Related]
4. Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia.
Guo X; Zhang R; Liu J; Li M; Song C; Dovat S; Li J; Ge Z
PLoS One; 2015; 10(5):e0125429. PubMed ID: 25942645
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.
Jia M; Zhao HZ; Shen HP; Cheng YP; Luo ZB; Li SS; Zhang JY; Tang YM
Int J Lab Hematol; 2015 Oct; 37(5):631-40. PubMed ID: 25955539
[TBL] [Abstract][Full Text] [Related]
6. High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid.
Wu W; Zhu H; Fu Y; Shen W; Miao K; Hong M; Xu W; Fan L; Young KH; Liu P; Li J
Oncotarget; 2016 Apr; 7(16):21631-43. PubMed ID: 26950276
[TBL] [Abstract][Full Text] [Related]
7. Induction of LEF1 by MYC activates the WNT pathway and maintains cell proliferation.
Hao YH; Lafita-Navarro MC; Zacharias L; Borenstein-Auerbach N; Kim M; Barnes S; Kim J; Shay J; DeBerardinis RJ; Conacci-Sorrell M
Cell Commun Signal; 2019 Oct; 17(1):129. PubMed ID: 31623618
[TBL] [Abstract][Full Text] [Related]
8. LEF-1 drives aberrant β-catenin nuclear localization in myeloid leukemia cells.
Morgan RG; Ridsdale J; Payne M; Heesom KJ; Wilson MC; Davidson A; Greenhough A; Davies S; Williams AC; Blair A; Waterman ML; Tonks A; Darley RL
Haematologica; 2019 Jul; 104(7):1365-1377. PubMed ID: 30630973
[TBL] [Abstract][Full Text] [Related]
9. Histone acetylation by HBO1 (KAT7) activates Wnt/β-catenin signaling to promote leukemogenesis in B-cell acute lymphoblastic leukemia.
Wang H; Qiu Y; Zhang H; Chang N; Hu Y; Chen J; Hu R; Liao P; Li Z; Yang Y; Cen Q; Ding X; Li M; Xie X; Li Y
Cell Death Dis; 2023 Aug; 14(8):498. PubMed ID: 37542030
[TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding LEF1-AS1 Sponge miR-5100 Regulates Apoptosis and Autophagy in Gastric Cancer Cells via the miR-5100/DEK/AMPK-mTOR Axis.
Zhang H; Wang J; Wang Y; Li J; Zhao L; Zhang T; Liao X
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563178
[TBL] [Abstract][Full Text] [Related]
11. Current Research Progress of the Role of LncRNA LEF1-AS1 in a Variety of Tumors.
Zheng Q; Yu X; Zhang M; Zhang S; Guo W; He Y
Front Cell Dev Biol; 2021; 9():750084. PubMed ID: 34988073
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of LEF1 Impairs Myeloma Cell Growth Through Modulating CYLD/NF-κB Signaling.
Zhang G; Miao F; Liu K; Wu J; Xu J
Technol Cancer Res Treat; 2021; 20():15330338211034270. PubMed ID: 34269120
[TBL] [Abstract][Full Text] [Related]
13. Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networks.
Diedrich JD; Dong Q; Ferguson DC; Bergeron BP; Autry RJ; Qian M; Yang W; Smith C; Papizan JB; Connelly JP; Hagiwara K; Crews KR; Pruett-Miller SM; Pui CH; Yang JJ; Relling MV; Evans WE; Savic D
Leukemia; 2021 Nov; 35(11):3078-3091. PubMed ID: 33714976
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitor chidamide regulates the Wnt/β-catenin pathway by MYCN/DKK3 in B-ALL.
Zhao L; Lv C; Sun L; Li Q; Wang Y; Wu M; Wang Y; Guo Z; Bian S; Kong D; Lin L; Wang Y; Zhou J; Li Y
Invest New Drugs; 2021 Aug; 39(4):961-970. PubMed ID: 33566253
[TBL] [Abstract][Full Text] [Related]
15. The Role of Notch and Wnt Signaling in MSC Communication in Normal and Leukemic Bone Marrow Niche.
Takam Kamga P; Bazzoni R; Dal Collo G; Cassaro A; Tanasi I; Russignan A; Tecchio C; Krampera M
Front Cell Dev Biol; 2020; 8():599276. PubMed ID: 33490067
[TBL] [Abstract][Full Text] [Related]
16. B-ALL Complexity: Is Targeted Therapy Still A Valuable Approach for Pediatric Patients?
Ratti S; Lonetti A; Follo MY; Paganelli F; Martelli AM; Chiarini F; Evangelisti C
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33255367
[TBL] [Abstract][Full Text] [Related]
17. Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment.
Ruan Y; Kim HN; Ogana H; Kim YM
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872365
[TBL] [Abstract][Full Text] [Related]
18. High expression of LEF1 correlates with poor prognosis in solid tumors, but not blood tumors: a meta-analysis.
Yang X; Liu H; Ye T; Ye Z
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32856045
[TBL] [Abstract][Full Text] [Related]
19. Suppression of CXCL-1 Could Restore Necroptotic Pathway in Chronic Lymphocytic Leukemia.
Xu Z; Sun Y; Wei Z; Jiang J; Xu J; Liu P
Onco Targets Ther; 2020; 13():6917-6925. PubMed ID: 32764983
[TBL] [Abstract][Full Text] [Related]
20.
Sırma Ekmekci S; Emrence Z; Abacı N; Sarıman M; Salman B; Ekmekci CG; Güleç Ç
Turk J Haematol; 2020 Nov; 37(4):226-233. PubMed ID: 32586085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
